Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy.
- Resource Type
- Article
- Source
- AAPS Journal; Jul2022, Vol. 24 Issue 4, p1-9, 9p
- Subject
- Language
- ISSN
- 15507416